Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.

Dokumenttyp:: Correction; Published Erratum
Autor(en):: Ohlmann, Carsten-Henning; Jäschke, Michelle; Jaehnig, Peter; Krege, Susanne; Gschwend, Jürgen; Rexer, Heidrun; Junker, Kerstin; Zillmann, Roger; Rüssel, Christoph; Hellmis, Eva; Suttmann, Henrik; Janssen, Martin; Marin, Jan; Hübner, Andreas; Mathers, Michael; Gleißner, Jochen; Scheffler, Michael; Feyerabend, Susan; Telle, Jens; Klier, Jörg; Stöckle, Michael
Titel:: Correction to: LHRH sparing therapy in patients with chemotherapy-naïve, mCRPC treated with abiraterone acetate plus prednisone: results of the randomized phase II SPARE trial.
Zeitschriftentitel:: Prostate Cancer Prostatic Dis
Jahr:: 2023
Band / Volume:: 26
Heft / Issue:: 4
Volltext / DOI:: doi:10.1038/s41391-023-00682-2
PubMed:: http://view.ncbi.nlm.nih.gov/pubmed/37253975
Print-ISSN:: 1365-7852
TUM Einrichtung:: Klinik und Poliklinik für Urologie (Prof. Gschwend)
BibTeX

Vorkommen: